Meta-analysis of Single-cell RNA-seq Data Reveals the Formation of Tertiary Lymphoid Organ and Mechanism Heterogeneity in Vascular Disease
Ontology highlight
ABSTRACT:
ORGANISM(S): Mus musculus
PROVIDER: GSE234651 | GEO | 2023/10/04
REPOSITORIES: GEO
Similar Datasets
Project description:Global gene expression patterns of the iCMs shift from a MEF state toward a cardiac-like phenotype by Gata4/Mef2c/Tbx5 (GMT) or GMT/Hand2 (GHMT) transduction at 2 and 4 weeks after transduction (2W, 4W). Hand2 upregulated a panel of cardiac genes and suppressed cell cylce genes during cardiac reprogramming.
2017-09-26 | GSE101578 | GEO
Project description:Restenosis is an inescapable problem when patients underwent percutaneous transluminal angioplasty because of intimal hyperplasia. Human umbilical cord mesenchymal stem cells derived exosomes (HucMSC-Exo) have been proved to promote reendothelialization to restrain the process of intimal hyperplasia. However, aberrant vascular smooth muscle cell (VSMC) proliferation, migration and dedifferentiation play more important roles in intimal hyperplasia, the effects and mechanisms of HucMSC-Exo upon VSMC are elusive
2022-12-30 | GSE188896 | GEO
Project description:PGC1α regulates the mitochondrial metabolism response to cyclic stretch, which inhibits neointimal hyperplasia microscopy revealed that intimal injury disrupted the balance of vascular energy metabolism and impaired the mitochondrial ultrastructure in vivo. The human carotid plaque and femoral artery plaque samples also exhibited alterations in mitochondrial morphology. Vascular smooth muscle cells (VSMCs) are the main components of neointimal hyperplasia and are subjected to cyclic stretch resulting from pulsatile pressure. In this study, we found that the application of cyclic stretch in vitro increased VSMC mitochondrial mass and function. In addition, peroxisome proliferator-activated receptor gamma coactivator-1α (PGC1α) played an important role in regulating VSMC mitochondrial function in response to physiological stretch via the phosphorylation of Smad3. Increasing the activation of PGC1α by ZLN005 treatment effectively inhibited VSMC hyperproliferation after intimal injury in vivo. These results suggested that the regulation of PGC1α by p-Smad3 in response to physiological cyclic stretch may effectively alleviate neointimal hyperplasia by promoting mitochondrial function. PGC1α may be a potential therapeutic target for the prevention and treatment of neointimal hyperplasia.
2025-08-13 | GSE285663 | GEO
Project description:Neointimal hyperplasia (IH) is a primary etiology of stenotic vascular diseases. It is perpetuated principally by smooth muscle cell proliferation. Epigenome-scale studies concerning IH have been confined to in vitro models, and the IH-underlying epigenetic mechanisms remain poorly understood. The current study has integrated information from in vivo epigenomic mapping, conditional knockout, gene transfer and pharmacology in rodent models of IH. The data from injured (IH-prone) rat arteries revealed a surge of genomewide occupancy by H3K27me3, a gene repression mark. This was unexpected in the traditional view of prevailing post-injury gene activation rather than repression. Further analysis illustrated a shift of H3K27me3 enrichment to anti-proliferative genes, from pro-proliferative genes where gene activation mark H3K27ac instead accumulated. In accordance, H3K27ac and its reader BRD4 co-enriched at Ezh2 governing its expression. Moreover, H3K27me3 writer EZH2 positively regulated another recently identified pro-IH chromatin modulator UHRF1. Thus, results unravel injury-induced loci-specific H3K27me3 redistribution in the epigenomic landscape entailing BRD4->EZH2->UHRF1 hierarchical regulations, and may guide translation to treat IH given that these players are pharmaceutical targets.
2022-02-14 | GSE194390 | GEO
Project description:Aberrantly remodeled vasculature in pulmonary arterial hypertension (PAH) features a prominent inflammatory cell infiltrate suggesting that immune effector cells may contribute to disease progression. Global expression studies of peripheral blood mononuclear cells (PBMCs) and whole blood have attempted to better define this inflammatory component of PAH pathobiology.
2019-10-08 | GSE131793 | GEO
Project description:Venous neointimal hyperplasia, characterized by the abnormal proliferation of smooth muscle cells (SMCs), represents a critical contributor to vascular stenosis and therapeutic failure in vascular interventions. Here, we identified a novel role of spatiotemporal nucleolar expression of DExH-box helicase 9 (DHX9) and its binding partner, the long non-coding RNA (lncRNA) MIAT in venous neointimal pathogenesis. In normal SMCs, DHX9 transiently localized to nucleoli during the early S phase. Pathologically, endogenous-activated MIAT facilitated nucleolar DHX9 location and its interaction with PARP1. Activated-MIAT induced mitotic spindle pole location of DHX9 which was destroyed by PARP inhibitor. MIAT also drove SMCs proliferation by accelerating cell cycle progression. While depleting MIAT or DHX9 led to remarkable nucleolar subphase disruption, mitotic breakage-fusion-bridge, and DNA damage. Of note, nucleolar-associated morphology phenotypes analyzed with deep learning are determined to be valuable biomarkers for assessing cellular status and disease progress. MIAT was repressed in cultured human veins, reducing SMCs proliferation and vascular intimal hyperplasia. These results establish the MIAT-DHX9 axis as the central regulator of venous SMCs in arteriovenous fistula and venous graft models. Our study may provide a new avenue to destroy the pathologic spatiotemporal function of DHX9 by targeting MIAT in intimal hyperplasia.
2025-09-25 | GSE308756 | GEO
Project description:Venous neointimal hyperplasia, characterized by the abnormal proliferation of smooth muscle cells (SMCs), represents a critical contributor to vascular stenosis and therapeutic failure in vascular interventions. Here, we identified a novel role of spatiotemporal nucleolar expression of DExH-box helicase 9 (DHX9) and its binding partner, the long non-coding RNA (lncRNA) MIAT in venous neointimal pathogenesis. In normal SMCs, DHX9 transiently localized to nucleoli during the early S phase. Pathologically, endogenous-activated MIAT facilitated nucleolar DHX9 location and its interaction with PARP1. Activated-MIAT induced mitotic spindle pole location of DHX9 which was destroyed by PARP inhibitor. MIAT also drove SMCs proliferation by accelerating cell cycle progression. While depleting MIAT or DHX9 led to remarkable nucleolar subphase disruption, mitotic breakage-fusion-bridge, and DNA damage. Of note, nucleolar-associated morphology phenotypes analyzed with deep learning are determined to be valuable biomarkers for assessing cellular status and disease progress. MIAT was repressed in cultured human veins, reducing SMCs proliferation and vascular intimal hyperplasia. These results establish the MIAT-DHX9 axis as the central regulator of venous SMCs in arteriovenous fistula and venous graft models. Our study may provide a new avenue to destroy the pathologic spatiotemporal function of DHX9 by targeting MIAT in intimal hyperplasia.
2025-09-25 | GSE308700 | GEO
Project description:Adult vascular smooth muscle cells (VSMCs) dedifferentiate in response to extracellular cues such as vascular damage and inflammation. Dedifferentiated VSMCs are proliferative, migratory, less contractile, and can contribute to vascular repair as well as to cardiovascular pathologies such as intimal hyperplasia/restenosis in coronary artery and arterial aneurysm. We here demonstrate the role of ubiquitin-like containing PHD and RING finger domains 1 (UHRF1) as an epigenetic master regulator of VSMC plasticity. UHRF1 expression correlated with the development of vascular pathologies associated with modulation of noncoding RNAs, such as microRNAs. miR-145 — pivotal in regulating VSMC plasticity, which is reduced in vascular diseases — was found to control Uhrf1 mRNA translation. In turn, UHRF1 triggered VSMC proliferation, directly repressing promoters of cell-cycle inhibitor genes (including p21 and p27) and key prodifferentiation genes via the methylation of DNA and histones. Local vascular viral delivery of Uhrf1 shRNAs or Uhrf1 VSMC-specific deletion prevented intimal hyperplasia in mouse carotid artery and decreased vessel damage in a mouse model of aortic aneurysm. Our study demonstrates the fundamental role of Uhrf1 in regulating VSMC phenotype by promoting proliferation and dedifferentiation. UHRF1 targeting may hold therapeutic potential in vascular pathologies.
2018-12-05 | GSE99472 | GEO
Project description:Intermittent hypoxia (IH) in HeLa cell culture activates proinflammatory transcription factor NFκB, whereas chronic hypoxia (CH) does not. In order to determine whether IH may be linked to vascular inflammation, we developed a novel IH cell culture system and exposed HAEC (human aortic endothelial cells) to IH or CH. Keywords: Human Artery Endothelial Cells (HAEC)
2008-12-31 | GSE10723 | GEO
Project description:Vascular smooth muscle cells (VSMCs) possess significant phenotypic plasticity, shifting between a contractile phenotype and a synthetic state for vascular repair/remodelling. Dysregulated VSMC transformation, marked by excessive proliferation and migration, primarily drives intimal hyperplasia. N6-methyladenosine (m6A), the most prevalent RNA modification in eukaryotes, plays a critical role in gene expression regulation; however, its impact on VSMC plasticity is not fully understood. This research investigates the alterations in m6A modification and its regulatory factors during VSMC phenotypic shifts and their influence on intimal hyperplasia. We demonstrate that METTL14, crucial for m6A deposition, significantly promotes VSMC dedifferentiation. METTL14 expression, initially negligible, is elevated in synthetic VSMC cultures, post-injury neointimal VSMCs, and human restenotic arteries. Reducing Mettl14 levels in mouse primary VSMCs decreases pro- synthetic genes, suppressing their proliferation and migration. m6A-RIP-seq profiling shows key VSMC gene networks undergo altered m6A regulation in Mettl14-deficient cells. Mettl14 enhances Klf4 and Serpine1 expression through increased m6A deposition. Local Mettl14 knockdown significantly curbs neointimal formation post-arterial injury, and reducing Mettl14 in hyperplastic arteries halts further neointimal development. We found that Mettl14 is a pivotal regulator of VSMC dedifferentiation, influencing Klf4- and Serpine1- mediated phenotypic conversion. Inhibiting Mettl14 is a viable strategy for preventing restenosis and halting restenotic occlusions
2025-03-17 | GSE291560 | GEO